Addex Therapeutics, Ltd. - היקף יתרות המזומנים של החברה ADXN

Addex Therapeutics (ADXN) is protected by exclusive patents and substantial R&D investments. The company's cash liquidity on the GURU.Markets terminal line chart visualizes these barriers, where the 0.00 mark serves as the current indicator. The business is penetrating the rare pathology niche through alliances with pharma behemoths. However, a heavy reliance on external financing creates risks in the event of unsuccessful research.
פילוחים אנליטיים ודוחות נתונים של חברת Addex Therapeutics Ltd (ADXN)

This indicator is calculated as the sum of highly liquid assets and cash on the organization's accounts. It determines the financial autonomy and the ability of the business to maintain operational activities without external borrowings. For Addex Therapeutics (ADXN), which lacks regular revenue, this reserve is critical for funding clinical trials. The cash balance trend reflects the company's dependence on partner infusions. A decline in this metric signals a reduction in the biopharmaceutical startup's "margin of safety."